2 recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Peter Caravan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis [68Ga]CBP8, Gadoterate Meglumine - Interstitial Lung Disease, Pulmonary Fibrosis | Phase 2 | Recruiting | Peter Caravan | 15 | 2026-05-14 | 2026-07-14 |
| Advanced Imaging for Pulmonary Fibrosis [68Ga]CBP8, Gadoterate Meglumine - Pulmonary Fibrosis | Phase 2 | Recruiting | Peter Caravan | 60 | 2025-01-21 | 2026-04-22 |
| PET Fibrin Imaging of DVT and PE 64Cu-FBP8, PET-CT imaging - Pulmonary Embolism, Deep Vein Thrombosis | Phase 1 | Terminated | Peter Caravan | 6 | 2019-05-13 | 2026-03-18 |
Pulmonary Fibrosis (2) · Lung Diseases, Interstitial (1) · Pulmonary Embolism (1) · Venous Thromboembolism (1) · Venous Thrombosis (1)
United States (3)
Sydney Montesi, MD (2) · Tilo Winkler, PhD (1)
R01HL141900 (1), R01HL171240 (1)